Re: NIH Submission outcomes -- anyone miss the deadline Cappellucci, James E. 10 Feb 2011 17:27 EST

 Hi There Bob!

We got the word out early & often. We did fine.

James Cappellucci
Sr. Grant Administrator, Grants & Contracts
Partners Healthcare/Massachusetts General Hospital
101 Huntington Avenue, 3rd Floor, Suite 300
Boston, MA 02199
Phone 617-954-9858
Fax: 617-954-9850
Main: 617-954-9660
xxxxxx@partners.org

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On
Behalf Of Bob Beattie
Sent: Thursday, February 10, 2011 4:40 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] NIH Submission outcomes -- anyone miss the deadline

Hi All
We have now passed the NIH RO1 Deadline, with the removal of the 2 day
correction window.  There was some apprehension on this change.

I am wondering if any one did miss getting an application into the Commons due
to the change?

Post your experiences so we can all know how it went.    Thanks

Bob
___________________________________
Robert Beattie
Managing Senior Project Representative
Division of Research Development and Administration
University of Michigan
3003 S. State Street     Ann Arbor, MI  48109-1274
office: 734 936-1283
xxxxxx@umich.edu

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.healthresearch.org (click on the
 "LISTSERV" link in the upper right corner)
======================================================================

The information in this e-mail is intended only for the person to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.healthresearch.org (click on the
 "LISTSERV" link in the upper right corner)
======================================================================